GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells

Abstract

Glioblastoma multiforme is the most aggressive primary brain cancer in adults. Therefore, it is important to investigate the mechanisms associated with cell viability and invasion ability of the cells in glioblastoma multiforme. The opposite strand of the glial cell line-derived neurotrophic factor (GDNF) gene is used to transcribe the cis-antisense GDNF opposite strand (GDNFOS) gene, which belongs to the long noncoding RNAs. The current study assessed the effects of GDNFOS1 overexpression and interference on GDNF expression, cell viability and invasion ability in U87 and U251 MG glioblastoma cells. Overexpression and interference were performed using constructed lentiviral vectors, including long non-coding RNA GDNFOS1 overexpression vector, pL-short hairpin RNA (shRNA)-GDNFOS1-9, pL-shRNA-GDNFOS1-49, pL-shRNA-GDNFOS1-248, pL-shRNA-GDNFOS1-9+49, pL-shRNA-GDNFOS1-9+248 and pL-shRNA-GDNFOS1-49+248. Reverse transcriptionquantitative PCR was used to determine the efficiency of interference and overexpression of GDNFOS1 in U87 and U251 MG cells. GDNF protein expression in U87 and U251 MG cells was detected using western blot analysis. In addition, cell viability was detected using a cell counting kit-8 assay at 24, 48 and 72 h after GDNFOS1 overexpression or interference. A transwell invasion assay was used to detect invasion ability. Different shRNA sequences were tested and the results revealed that a combination (pL-shRNA-GDNFOS1-49+248) was most effective in the knock-down GDNFOS1. Compared with the control group, GDNF expression in U87 MG cells was significantly increased in the GDNFOS1 overexpression group and decreased in the shRNA-GDNFOS1-248 group. U87 MG cell viability was significantly increased in the GDNFOS1 overexpression group at 24, 48 and 72 h compared with the negative control group. The viability of U87 MG cells was decreased in the GDNFOS1 interference group at 72 h when compared with the control group. The relative invasive ability was significantly increased in the GDNFOS1 overexpression group when compared with the negative control group. The invasive ability was significantly decreased in the GDNFOS1 interference group when compared with the negative control group. Similar results were exhibited by the U251 MG cells. Overall, GDNF expression, cell viability and invasion ability of glioblastoma cells significantly increased with GDNFOS1 overexpression and decreased with GDNFOS1 interference.

Glioblastoma - actual knowledge and future perspectives

“…aon-dRR aon against cd44 and epha2 reduce dRR/FaM107a expression in vitro, tissue invasion ↓ cell metastasis ↓, less invasive phenotype [71] circ-piTX1 downregulation of circ-piTX1 -cell proliferation ↓, apoptosis ↑ in vitro, circ-piTX1 is a sponge for miR-379-5p, the elevation of Map3K2 expression [72] miR-128 pHB-co-pei nanoparticles loaded with miR-128 encoding plasmid increased apoptosis by 24,5% in vitro [73] miR-155 when overexpressed -cell proliferation ↓, invasion ↓ and foci formation ↓, targets agTR1/nF-κB/ cXcR4 pathway [74] miR-7 downregulation of miR-7 causes overexpression of TBX2 -migration ability ↑ of gBM cells in vitro [75] miRna-181a pi3K/aKT ↓ when overexpressed -sensitivity to carmustine ↑ via regulation of caspase-9, Bcl-2, siRT1, migration ↓ via downregulation of MMp-2 and Bach1, g1 cell cycle arrest, apoptosis ↑ [76] shRna-aRRB1 delayed cell cycle progression and proliferation sensitivity ↑ to nK1R antagonists, g2/M transition arrest, downregulation of cdc25c/cdK1/cyclin B [77] shRna-gdnFos gdnFos1 interference -invasion ability ↓ and cell viability ↓ [78] shRna-slp2 chitosan hydrogen contained irinotecan -cell apoptosis ↑ in vitro, shRna reduced slp2 protein expression -cell migration ↓, tumor size ↓ in a murine model [79] siRna-aTM Rgd-peg-eco nanoparticles -efficient delivery, radiosensitivity ↑ in vitro [80] siRna-cd73 nasal administration in rats -cell apoptosis ↑, Treg ↓, microglia ↓ and macrophages ↓ in the tumor microenvironment; il-6 ↑, ccl17 ↑, ccl22 ↑ [81] siRna-gal1 chitosan nanoparticles administered intranasally -tumor cell motility ↓, gal-1 expression ↓ [82] siRna-golM1 proliferation ↓, g1/s cell cycle arrest, tumor cell motility ↓, Wnt/β-catenin signaling ↓, tumor growth ↓ in a murine model [83] siRna-Hsp27+resveratrol silencing of Hsp27 in vitro and resveratrol have a synergistic effect on the induction of apoptosis [84] siRna-opn, shRna-opn Ko -the ability ↓ to recruit macrophages, T-cell effector activity ↑ in infiltrating the glioma in vitro, in vivo median survival time -by 68% in mice [85] siRna-plK1 and siRna -VegF2…”